The chemotherapy drug capecitabine gives patients a better quality of life and is as effective at preventing breast cancer from returning as the alternative CMF
Cancer Research UK statement on the death of Professor Patrick Johnston in Belfast.
Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent.
A new report reveals that partnerships between UK and EU medical researchers have increased the value of research, benefiting patients across Europe
Stagnant Brits struggle to walk more than a mile a day according to new research from Cancer Research UK’s Walk All Over Cancer campaign published today.